Shore Capital Group Reaffirms House Stock Rating for Anpario (LON:ANP)

Anpario (LON:ANP – Get Free Report)‘s stock had its “house stock” rating restated by research analysts at Shore Capital Group in a research note issued on Monday,London Stock Exchange reports.

Separately, Canaccord Genuity Group reissued a “buy” rating and set a GBX 570 price objective on shares of Anpario in a research note on Friday, June 26th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of GBX 570.

Get Anpario alerts:

Read Our Latest Analysis on ANP

Anpario Stock Performance

Shares of Anpario stock opened at GBX 530 on Monday. The firm has a fifty day moving average of GBX 529.37 and a two-hundred day moving average of GBX 520.54. The stock has a market capitalization of £86.32 million, a price-to-earnings ratio of 13.97 and a beta of 1.08. Anpario has a 52 week low of GBX 391.11 and a 52 week high of GBX 580. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 4.50.

Anpario declared that its board has authorized a stock buyback program on Monday, April 27th that allows the company to buyback 0 outstanding shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Articles

• Five stocks we like better than Anpario
• The Metals Company’s Big Bet Now Comes Down to a License
• OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
• Meta and Tesla Are Rebounding From Oversold Levels—Now What?
• AMG’s Alternatives Boom Powers Record Growth

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.